Heron Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Heron Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18% to $127,044,000. The net income raised on -$110,559,000 and profit margin reached -87%. Total operating expenses were $120,657,000.
Profit Margin
| 2014 | 0 | -76.36M | |
|---|---|---|---|
| 2015 | 0 | -97.59M | |
| 2016 | 1.27M | -173.14M | -13537.37% |
| 2017 | 30.76M | -197.48M | -641.87% |
| 2018 | 77.47M | -178.84M | -230.84% |
| 2019 | 145.96M | -204.74M | -140.27% |
| 2020 | 88.63M | -227.27M | -256.41% |
| 2021 | 86.34M | -220.68M | -255.58% |
| 2022 | 107.67M | -182.02M | -169.05% |
| 2023 | 127.04M | -110.55M | -87.02% |
0J4V.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 127.04M | 107.67M | 86.34M | 88.63M | 145.96M | 77.47M | 30.76M | 1.27M | 0 | 0 |
Cost of revenue | 117.00M | 54.87M | 46.02M | 36.18M | 61.61M | 167.54M | 4.58M | 103.16M | 734K | 54.83M |
Gross profit | 10.04M | 52.79M | 40.32M | 52.44M | 84.34M | -90.07M | 26.17M | -101.88M | -734K | -54.83M |
Operating exp. | ||||||||||
Research and development | 55.89M | 103.30M | 130.82M | 174.53M | 167.38M | 140.03M | 137.08M | 103.12M | 61.18M | 54.83M |
Selling and marketing | 61.34M | 81.51M | 86.97M | 63.15M | 89.76M | 64.60M | 56.60M | 47.66M | 17.34M | 8.70M |
Total operating expenses | 120.65M | 222.05M | 256.55M | 280.61M | 295.04M | 92.06M | 218.93M | 69.04M | 96.19M | 20.65M |
Operating income | -110.61M | -169.25M | -216.22M | -228.16M | -210.69M | -183.93M | -192.75M | -170.91M | -96.92M | -74.56M |
Other income (expenses), net | 56K | -12.76M | -4.45M | 885K | 5.94M | 5.09M | -4.72M | -2.22M | -666K | -1.80M |
Income before tax | -110.55M | -182.02M | -220.68M | -227.27M | -204.74M | -178.84M | -197.48M | -173.14M | -97.59M | -76.36M |
Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income | -110.55M | -182.02M | -220.68M | -227.27M | -204.74M | -178.84M | -197.48M | -173.14M | -97.59M | -76.36M |
Earnings per share | ||||||||||
Basic EPS | -0.8 | -1.67 | -2.24 | -2.5 | -2.5 | -2.44 | -3.65 | -4.57 | -2.95 | -2.87 |
Diluted EPS | -0.8 | -1.67 | -2.24 | -2.5 | -2.5 | -2.44 | -3.65 | -4.57 | -2.95 | -2.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |